152 related articles for article (PubMed ID: 11828833)
1. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers.
Valuck RJ; Perlman JI; Anderson C; Wortman GI
Pharmacoepidemiol Drug Saf; 2001; 10(6):511-6. PubMed ID: 11828833
[TBL] [Abstract][Full Text] [Related]
2. Brief report: beta-blocker use among veterans with systolic heart failure.
Sinha S; Goldstein M; Penrod J; Hochman T; Kamran M; Tenner C; Cohen G; Schwartz MD
J Gen Intern Med; 2006 Dec; 21(12):1306-9. PubMed ID: 17105526
[TBL] [Abstract][Full Text] [Related]
3. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
[TBL] [Abstract][Full Text] [Related]
4. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
Mascarenhas J; Azevedo A; Bettencourt P
Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
[TBL] [Abstract][Full Text] [Related]
5. Topical glaucoma medications and cardiovascular risk in the elderly.
Monane M; Bohn RL; Gurwitz JH; Glynn RJ; Choodnovskiy I; Avorn J
Clin Pharmacol Ther; 1994 Jan; 55(1):76-83. PubMed ID: 7905370
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.
Han JA; Frishman WH; Wu Sun S; Palmiero PM; Petrillo R
Cardiol Rev; 2008; 16(2):95-108. PubMed ID: 18281912
[TBL] [Abstract][Full Text] [Related]
7. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.
Au DH; Bryson CL; Fan VS; Udris EM; Curtis JR; McDonell MB; Fihn SD
Am J Med; 2004 Dec; 117(12):925-31. PubMed ID: 15629731
[TBL] [Abstract][Full Text] [Related]
9. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
Good CB
Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
[No Abstract] [Full Text] [Related]
10. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.
Ormiston TM; Salpeter SR
Heart Fail Monit; 2003; 4(2):45-54. PubMed ID: 14724718
[TBL] [Abstract][Full Text] [Related]
11. [Beta-blocker prescription and chronic obstructive pulmonary disease].
Ollivier R; Donal E; Delaval P; Daubert JC; Mabo P
Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):231-6. PubMed ID: 17854758
[TBL] [Abstract][Full Text] [Related]
12. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
Rutten FH
Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
[TBL] [Abstract][Full Text] [Related]
13. Managing glaucoma in those with co-morbidity: not as easy as it seems.
Roughead EE; Kalisch LM; Pratt NL; Killer G; Barnard A; Gilbert AL
Ophthalmic Epidemiol; 2012 Apr; 19(2):74-82. PubMed ID: 22364388
[TBL] [Abstract][Full Text] [Related]
14. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
15. Topical beta-blockers are not associated with an increased risk of treatment for depression.
Kaiserman I; Kaiserman N; Elhayany A; Vinker S
Ophthalmology; 2006 Jul; 113(7):1077-80. PubMed ID: 16815397
[TBL] [Abstract][Full Text] [Related]
16. Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure.
Shelton RJ; Rigby AS; Cleland JG; Clark AL
Heart; 2006 Mar; 92(3):331-6. PubMed ID: 15951394
[TBL] [Abstract][Full Text] [Related]
17. beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.
Barnett MJ; Milavetz G; Kaboli PJ
Pharmacotherapy; 2005 Nov; 25(11):1550-9. PubMed ID: 16232018
[TBL] [Abstract][Full Text] [Related]
18. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
19. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
Nygaard HA; Høvding G
Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
[TBL] [Abstract][Full Text] [Related]
20. Wheezy patient with heart failure and chronic obstructive pulmonary disease: what to treat with?
Palaniswamy C; Guleria R; Mohan A; Selvaraj DR
Am J Emerg Med; 2008 Nov; 26(9):1060. PubMed ID: 19091275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
